AFTER CORRECTING FOR WORSE BASELINE CHARACTERISTICS , WOMAN TREATED WITH THROMBOLYTIC THERAPY FOR AMI HAVE THE SAME MORTALITY AND MORBIDITY AS MEN EXCEPT FOR A HIGHER INCIDENCE OF HEMORRHAGIC STROKE

WHITE, H.D., BARBASH, G.I., & MODAN, M.. (1993). AFTER CORRECTING FOR WORSE BASELINE CHARACTERISTICS , WOMAN TREATED WITH THROMBOLYTIC THERAPY FOR AMI HAVE THE SAME MORTALITY AND MORBIDITY AS MEN EXCEPT FOR A HIGHER INCIDENCE OF HEMORRHAGIC STROKE. CIRCULATION, 88(5 PT 1), 2097-2103. SID. https://sid.ir/paper/598321/en

WHITE H.D., BARBASH G.I., MODAN M.. AFTER CORRECTING FOR WORSE BASELINE CHARACTERISTICS , WOMAN TREATED WITH THROMBOLYTIC THERAPY FOR AMI HAVE THE SAME MORTALITY AND MORBIDITY AS MEN EXCEPT FOR A HIGHER INCIDENCE OF HEMORRHAGIC STROKE. CIRCULATION[Internet]. 1993;88(5 PT 1):2097-2103. Available from: https://sid.ir/paper/598321/en

H.D. WHITE, G.I. BARBASH, and M. MODAN, “AFTER CORRECTING FOR WORSE BASELINE CHARACTERISTICS , WOMAN TREATED WITH THROMBOLYTIC THERAPY FOR AMI HAVE THE SAME MORTALITY AND MORBIDITY AS MEN EXCEPT FOR A HIGHER INCIDENCE OF HEMORRHAGIC STROKE,” CIRCULATION, vol. 88, no. 5 PT 1, pp. 2097–2103, 1993, [Online]. Available: https://sid.ir/paper/598321/en